These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 14520142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Linezolid for the treatment of complicated skin and skin structure infections in children.
    Yogev R, Patterson LE, Kaplan SL, Adler S, Morfin MR, Martin A, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
    [Abstract] [Full Text] [Related]

  • 3. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [Abstract] [Full Text] [Related]

  • 4. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
    Kaplan SL, Deville JG, Yogev R, Morfin MR, Wu E, Adler S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB, Linezolid Pediatric Study Group.
    Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
    [Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of linezolid in children.
    Saiman L, Goldfarb J, Kaplan SA, Wible K, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [Abstract] [Full Text] [Related]

  • 6. Hematologic effects of linezolid in young children.
    Meissner HC, Townsend T, Wenman W, Kaplan SL, Morfin MR, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
    [Abstract] [Full Text] [Related]

  • 7. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL, Afghani B, Lopez P, Wu E, Fleishaker D, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
    [Abstract] [Full Text] [Related]

  • 8. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF, Zhang YY, Wu JF, Wang F, Zheng JC, Miao JZ, Zheng LY, Sheng RY, Zhou X, Shen HH, Ijzerman MM, Croos-Dabrera RV, Sheng W.
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [Abstract] [Full Text] [Related]

  • 9. Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children.
    Wible K, Tregnaghi M, Bruss J, Fleishaker D, Naberhuis-Stehouwer S, Hilty M.
    Pediatr Infect Dis J; 2003 Apr; 22(4):315-23. PubMed ID: 12690270
    [Abstract] [Full Text] [Related]

  • 10. Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
    Beibei L, Yun C, Mengli C, Nan B, Xuhong Y, Rui W.
    Int J Antimicrob Agents; 2010 Jan; 35(1):3-12. PubMed ID: 19900794
    [Abstract] [Full Text] [Related]

  • 11. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Wilcox MH, Tack KJ, Bouza E, Herr DL, Ruf BR, Ijzerman MM, Croos-Dabrera RV, Kunkel MJ, Knirsch C.
    Clin Infect Dis; 2009 Jan 15; 48(2):203-12. PubMed ID: 19072714
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, Dukart G, Babinchak T, Cooper CA, Ellis-Grosse EJ, Dartois N, Gandjini H, 307 Study Group.
    J Antimicrob Chemother; 2008 Sep 15; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
    Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB, Tack KJ.
    Clin Infect Dis; 2006 Mar 01; 42(5):597-607. PubMed ID: 16447103
    [Abstract] [Full Text] [Related]

  • 14. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
    Rubinstein E, Cammarata S, Oliphant T, Wunderink R, Linezolid Nosocomial Pneumonia Study Group.
    Clin Infect Dis; 2001 Feb 01; 32(3):402-12. PubMed ID: 11170948
    [Abstract] [Full Text] [Related]

  • 15. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Shulman R, Singer M, Wilson AP.
    J Antimicrob Chemother; 2004 Feb 01; 53(2):345-55. PubMed ID: 14711840
    [Abstract] [Full Text] [Related]

  • 16. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ, Chiu CH, Lin TY, Lee ZL, Yang WE, Huang YC.
    Pediatr Infect Dis J; 2007 Nov 01; 26(11):985-8. PubMed ID: 17984803
    [Abstract] [Full Text] [Related]

  • 17. Preliminary experience with the use of oral linezolid in infants for the completion of antibiotic therapy in the outpatient setting after admission to the pediatric intensive care unit.
    Sullivan J, Tobias JD.
    Am J Ther; 2006 Nov 01; 13(6):473-7. PubMed ID: 17122526
    [Abstract] [Full Text] [Related]

  • 18. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
    Pulay I, Konkoly TM, Zsirka KA, Csapó Z, Flautner L, Tihanyi T.
    Orv Hetil; 2003 Jan 05; 144(1):29-33. PubMed ID: 12635350
    [Abstract] [Full Text] [Related]

  • 19. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
    Wilcox M, Nathwani D, Dryden M.
    J Antimicrob Chemother; 2004 Feb 05; 53(2):335-44. PubMed ID: 14729745
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of linezolid in liver transplant patients.
    Radunz S, Juntermanns B, Kaiser GM, Treckmann J, Mathe Z, Paul A, Saner FH.
    Transpl Infect Dis; 2011 Aug 05; 13(4):353-8. PubMed ID: 21355969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.